| |
This gentleman
presents with a common clinical scenario: Chest pain in a patient
with known coronary artery disease. The clinical questions here are (1)
Does this gentleman have progression of his atherosclerosis in RCA or
restenosis of his LAD lesion? (2) Does he need a catheter-based coronary
angiogram?
For patients
with typical exertional angina, direct catheter-based coronary angiogram
appears to be the most cost-effective approach. However, for those with
atypical symptoms, non-invasive tests should be considered first. A treadmill
stress test is easy and convenient. If the test is definitely positive,
life would be simple as what he needs then is a cardiac catheterization
to confirm any stenosis. However, if the treadmill test result is equivocal
or negative and yet the patient has persistent symptoms, one may feel
it difficult to leave the patient on simple medical treatment, given that
the treadmill stress test has limited sensitivity and specificity.
CT coronary
angiogram has a high negative predictive value. However, in this gentleman,
its usefulness may be limited because detailed assessment of in-stent
restenosis inside the previous stent would be difficult, particularly
with small stents. In addition, for known intermediate lesions like this
50% stenosis in RCA, the limited spatial resolution of CT coronary angiogram
may render it difficult to differentiate a 60% or a 40% stenosis from
a 50% one. Therefore, sometimes a CT coronary angiogram may not be able
to give a conclusive result in this scenario unless the progression of
the lesions is distinctively obvious. Presence of asthma does not preclude
the application of CT, especially if the baseline heart rate is in the
range of 60s/min, although steroid cover is recommended. If beta-blocker
is to be used due to high baseline heart rate, it may still be used with
caution if the asthma is in clinical remission and if it does not need
regular maintenance treatment. However, beta-blocker is contraindicated
in patients with active asthma.
Perhaps the
best non-invasive investigation in this gentleman is cardiac MRI. In cardiac
MRI, the anatomy of the coronary arteries is not shown and what it demonstrates
is the presence and absence of myocardial ischemia via perfusion defects
in adenosine perfusion stress MRI or via wall motion abnormalities in
dobutamine stress MRI. In this patient, since there are known coronary
lesions, the functional information on presence of ischemia appears to
be more important than the anatomical information. If there is ischaemia,
one can proceed to cardiac catheterization and if not, one can continue
medical treatment. Adenosine is a short acting drug that can cause bronchospasm.
In general, it should be safe for patients with mild asthma in remission
and for those who do not need regular maintenance treatment. Again, it
is contraindicated in patients with active asthma. On the other hand,
dobutamine stress cardiac MRI can be safely performed on patients with
a history of asthma. Cardiac MRI is not contraindicated in patients with
underlying asthma. In a way, adenosine cardiac MRI is similar to thallium
perfusion stress test and dobutamine stress MRI is similar to dobutamine
stress echocardiogram with cardiac MRI having a higher spatial resolution
and specificity.
Most if not
all coronary and peripheral vascular stents are MRI compatible. Cardiac
MRI may be safely performed a few weeks after stent deployment. In addition,
Amplatzer ASD/VSD/PFO/PDA occluders are also MRI compatible.
|